Limits...
Efficacy of a minimal home-based psychoeducative intervention versus usual care for managing anxiety and dyspnoea in patients with severe chronic obstructive pulmonary disease: a randomised controlled trial protocol.

Bove DG, Overgaard D, Lomborg K, Lindhardt BØ, Midtgaard J - BMJ Open (2015)

Bottom Line: In its final stages, chronic obstructive pulmonary disease is a severely disabling condition that is characterised by dyspnoea, which causes substantial anxiety.Anxiety is associated with an impaired quality of life and increased hospital admissions.However, the majority of existing interventions have tested the efficacy of relatively intensive comprehensive programmes and primarily targeted patients who have moderate pulmonary disease.

View Article: PubMed Central - PubMed

Affiliation: Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital, Nordsjælland, Hillerød, Denmark.

No MeSH data available.


Related in: MedlinePlus

Flow chart.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4499678&req=5

BMJOPEN2015008031F1: Flow chart.

Mentions: Patients with a confirmed COPD diagnosis, who were classified as category C or D according to the Global Initiative for Obstructive Lung Disease (GOLD),18 had an HADS-A subscale score of ≥8 and were willing to participate and able to provide written consent, were eligible for participation. Exclusion criteria were patients with HADS-A subscale score of <8, a psychiatric diagnosis, pulmonary cancer or involvement in a different interventional clinical trial. A preliminary diagram that shows the participant's flow through each stage of the randomised trial is illustrated in figure 1.


Efficacy of a minimal home-based psychoeducative intervention versus usual care for managing anxiety and dyspnoea in patients with severe chronic obstructive pulmonary disease: a randomised controlled trial protocol.

Bove DG, Overgaard D, Lomborg K, Lindhardt BØ, Midtgaard J - BMJ Open (2015)

Flow chart.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4499678&req=5

BMJOPEN2015008031F1: Flow chart.
Mentions: Patients with a confirmed COPD diagnosis, who were classified as category C or D according to the Global Initiative for Obstructive Lung Disease (GOLD),18 had an HADS-A subscale score of ≥8 and were willing to participate and able to provide written consent, were eligible for participation. Exclusion criteria were patients with HADS-A subscale score of <8, a psychiatric diagnosis, pulmonary cancer or involvement in a different interventional clinical trial. A preliminary diagram that shows the participant's flow through each stage of the randomised trial is illustrated in figure 1.

Bottom Line: In its final stages, chronic obstructive pulmonary disease is a severely disabling condition that is characterised by dyspnoea, which causes substantial anxiety.Anxiety is associated with an impaired quality of life and increased hospital admissions.However, the majority of existing interventions have tested the efficacy of relatively intensive comprehensive programmes and primarily targeted patients who have moderate pulmonary disease.

View Article: PubMed Central - PubMed

Affiliation: Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital, Nordsjælland, Hillerød, Denmark.

No MeSH data available.


Related in: MedlinePlus